The vector of anti-CEA chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CEA. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-CEA antibody linked to CD28 signaling domains. And the vector product was designed for the treatment of colon carcinoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-CAR-LC796||Lenti-CEA CAR (scFv-CD28-CD3ζ, SCA431) Viral Particle|
|CAR-WFY2856||Anti-CEACAM5 (CBFYC-1684) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-LC375||Anti-CEACAM5 h(CD28-CD3ζ, GITR) Armoured CAR, pCDCAR1|
|CAR-CQ0478||Anti-CEACAM5 (CBXC-1942) h(41BB-CD3ζ) CAR, pCDCAR1|
|VP-CAR-LC155||Lenti-CEA CAR (scFv-CD28-41BB-CD3ζ, BW431/26) Viral Particle|
|CAR-WFY6103||Anti-CEACAM5 (CBFYC-1678) h(CD28-CD3ζ) CAR, pCDCAR1|
|DMAb-0452-CQ||Mouse Anti-CEACAM5 DNA-encoded mAb (Clone CBXC-2571), pVAX1|
|DMAb-0457-CQ||Mouse Anti-CEACAM5 DNA-encoded mAb (Clone C66/1009), pVAX1|
|CAR-LC019||Anti-CEA h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-CQ0472||Anti-CEACAM5 (SPM584) h(41BB-CD3ζ) CAR, pCDCAR1|
Copyright © 2007 - 2019 Creative Biolabs. All Rights Reserved